Abstract
Blood borne virus (BBV) infection in adults involved in high risk behaviour is well recognized. There are limited reported data on young people involved in high risk behaviour. A descriptive questionnaire was used to ascertain risk behaviour at the Young People's Substance Misuse Service (Birmingham). Data collection included risk behaviour and serological tests for hepatitis B, C and HIV. Sixty-five of one-hundred three (63%) young people participated; 37/65 male; age range 13.9-18.9 (median 17.4 years). Risk behaviour included 6 intravenous drug, 58 cannabis, and 61 had sexual partners, of whom 52 (85%) engaged in unprotected sex. Sixty-five participants were negative for BBV infection: 9 were HBV immune. HB vaccination was not available at the centre (for <18 year), and all refused referral to their general practitioner for vaccination due to fear of disclosure. The main risk for BBV acquisition was unprotected sex with multiple sexual partners and illicit drug use. Most were unaware of the risks related to high risk behaviour. Effective education programmes of relevant risk factors with HBV vaccination should be implemented during preadolescence. We recommend an integrated service via specialized centres, to work together t...Continue Reading
References
Mar 22, 2006·AIDS·Rebecca F BaggaleyMichel Alary
Aug 2, 2006·Journal of Hepatology·Joseph F PerzBeth P Bell
Mar 6, 2007·Australian and New Zealand Journal of Public Health·Lisa MaherJohn M Kaldor
Sep 15, 2007·The International Journal on Drug Policy·Holly HaganPeter L Flom
Sep 27, 2008·Lancet·Bradley M MathersUNKNOWN 2007 Reference Group to the UN on HIV and Injecting Drug Use
Aug 2, 2011·Lancet·Paul K NelsonLouisa Degenhardt
Nov 23, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Khayriyyah Mohd HanafiahSteven T Wiersma
May 9, 2014·AIDS·Pragna PatelJonathan Mermin
Dec 8, 2016·Nature Reviews. Gastroenterology & Hepatology·Aaron P ThriftFasiha Kanwal
Mar 21, 2017·Annals of Internal Medicine·Oluwaseun Falade-NwuliaMark S Sulkowski
Mar 31, 2017·Microbial Cell·Takako Inoue, Yasuhito Tanaka
Mar 31, 2017·Microbial Cell·Juan C BecerraJohannes S Gach
May 20, 2017·Expert Opinion on Investigational Drugs·Vincent SorianoCarmen de Mendoza
Jul 12, 2017·Journal of the International AIDS Society·Sarah E RutsteinJoseph D Tucker
Oct 27, 2017·The Lancet Infectious Diseases·Nathan FordGottfried Hirnschall
Oct 28, 2017·The Lancet Global Health·Louisa DegenhardtSarah Larney
Jan 10, 2018·World Journal of Hepatology·Reza Taherkhani, Fatemeh Farshadpour